A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
LIC MF Healthcare Fund - Direct Plan
Regular
Direct
3 Year Absolute Returns
92.83% ↑
NAV (₹) on 08 May 2026
34.04
1 Day NAV Change
0.67%
Risk Level
Very High Risk
Rating
-
LIC MF Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by LIC Mutual Fund Asset Management Limited. Launched on 08 Feb 2019, investors can start with a minimum ... Read more
NAV History
Fund Details
Min. SIP Amount
₹200
Inception Date
08 Feb 2019
Min. Lumpsum Amount
₹ 5,000
Fund Age
7 Yrs
AUM
₹ 78.30 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
0.64%
Scheme Type
Open Ended
Exit Load
1%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 78.30 Cr
Equity
289.01%
Money Market & Cash
12.2%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 69.23% |
| Hospitals & Medical Services | 22.23% |
| Treps/Reverse Repo | 3.97% |
| Chemicals - Others | 3.24% |
| Chemicals - Organic - Benzene Based | 1.48% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 11.09% | ₹ 9.11 | Pharmaceuticals |
| Torrent Pharmaceuticals Ltd. | 6.93% | ₹ 5.69 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 6.87% | ₹ 5.64 | Hospitals & Medical Services |
| Fortis Healthcare Ltd. | 4.94% | ₹ 4.06 | Hospitals & Medical Services |
| Divi's Laboratories Ltd. | 4.81% | ₹ 3.95 | Pharmaceuticals |
| Aurobindo Pharma Ltd. | 4.65% | ₹ 3.82 | Pharmaceuticals |
| Piramal Pharma Ltd. | 4.30% | ₹ 3.53 | Pharmaceuticals |
| Neuland Laboratories Ltd. | 4.04% | ₹ 3.32 | Pharmaceuticals |
| Treps | 3.90% | ₹ 3.20 | Others |
| Onesource Specialty Pharma Ltd. | 3.63% | ₹ 2.98 | Pharmaceuticals |
| Alkem Laboratories Ltd. | 3.44% | ₹ 2.82 | Pharmaceuticals |
| Cipla Ltd. | 3.21% | ₹ 2.64 | Pharmaceuticals |
| Navin Fluorine International Ltd. | 3.14% | ₹ 2.58 | Chemicals - Others |
| Abbott India Ltd. | 3.13% | ₹ 2.57 | Pharmaceuticals |
| Gland Pharma Ltd. | 3.12% | ₹ 2.56 | Pharmaceuticals |
| Glenmark Pharmaceuticals Ltd. | 3.12% | ₹ 2.56 | Pharmaceuticals |
| IPCA Laboratories Ltd. | 3.09% | ₹ 2.54 | Pharmaceuticals |
| Concord Biotech Ltd. | 3.05% | ₹ 2.51 | Pharmaceuticals |
| Metropolis Healthcare Ltd. | 2.74% | ₹ 2.25 | Hospitals & Medical Services |
| Artemis Medicare Services Ltd. | 2.73% | ₹ 2.24 | Hospitals & Medical Services |
| Mankind Pharma Ltd. | 2.35% | ₹ 1.93 | Pharmaceuticals |
| Max Healthcare Institute Ltd. | 2.23% | ₹ 1.83 | Hospitals & Medical Services |
| Dr Agarwal's Health Care Ltd. | 2.18% | ₹ 1.79 | Hospitals & Medical Services |
| Anthem Biosciences Ltd. | 2.16% | ₹ 1.78 | Pharmaceuticals |
| Global Health Ltd. | 2.07% | ₹ 1.70 | Hospitals & Medical Services |
| Acutaas Chemicals Ltd. | 1.65% | ₹ 1.36 | Pharmaceuticals |
| Vinati Organics Ltd. | 1.57% | ₹ 1.29 | Chemicals - Organic - Benzene Based |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 8.09% | 14.29% | 14.90% | 24.47% |
| Category returns | 5.29% | 9.71% | 11.26% | 24.26% |
Fund Objective
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
AMC Details
Name
LIC Mutual Fund Asset Management Limited
Date of Incorporation
20 Apr 1994
CEO
Mr. Ravi Kumar Jha
CIO
Mr. Nikhil Rungta,Mr. Yogesh Patil
Type
Institution
Address
4th Floor,
Industrial Assurance Building,
Opp. Churchgate Station Mumbai, Maharashtra, India - 400020
Website
http://www.licmf.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Aditya Birla Sun Life Business Cycle Fund - Direct Plan
Diversified
Direct
|
₹14.06 | 0.86% | 32.89% | 0.00% | ₹1,540 | 1.19% |
Very High
|
|
Aditya Birla Sun Life Business Cycle Fund - Direct Plan
Diversified
Direct
|
₹14.06 | 0.86% | 32.89% | 0.00% | ₹1,540 | 1.19% |
Very High
|
|
ICICI Prudential Technology Fund
Sector
Regular
|
₹172.23 | -8.43% | 32.83% | 53.33% | ₹12,575 | 1.78% |
Very High
|
|
DSP Quant Fund
Largecap
Regular
|
₹21.32 | 5.53% | 32.81% | 51.75% | ₹735 | 1.27% |
Very High
|
|
Tata Digital India Fund - Direct Plan
Sector
Direct
|
₹46.54 | -10.09% | 32.70% | 59.12% | ₹9,239 | 0.56% |
Very High
|
|
Aditya Birla Sun Life ESG Integration Strategy Fund -...
Sector
Direct
|
₹16.50 | -1.26% | 32.64% | 57.74% | ₹522 | 1.44% |
Very High
|
|
Aditya Birla Sun Life ESG Integration Strategy Fund -...
Sector
Direct
|
₹16.50 | -1.26% | 32.64% | 57.74% | ₹522 | 1.44% |
Very High
|
|
HDFC Banking & Financial Services Fund
Sector
Regular
|
₹15.37 | 7.90% | 32.42% | 0.00% | ₹3,870 | 1.92% |
Very High
|
|
HDFC Banking & Financial Services Fund
Sector
Regular
|
₹15.37 | 7.90% | 32.42% | 0.00% | ₹3,870 | 1.92% |
Very High
|
|
SBI MNC Fund - Direct Plan
MidsmallCap
Direct
|
₹421.13 | 7.92% | 32.32% | 66.51% | ₹5,329 | 1.30% |
Very High
|
Top Funds from LIC Mutual Fund Asset Management Limited
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
LIC MF Nifty 50 Index Fund
Index
Regular
|
₹49.11 | -0.36% | 32.41% | 63.58% | ₹335 | 1.08% |
Very High
|
|
LIC MF Nifty 50 Index Fund
Index
Regular
|
₹49.11 | -0.36% | 32.41% | 63.58% | ₹335 | 1.08% |
Very High
|
|
LIC MF Nifty 50 Index Fund
Index
Regular
|
₹133.12 | -0.36% | 32.41% | 63.58% | ₹335 | 1.08% |
Very High
|
|
LIC MF Equity Savings Fund
Hybrid
Regular
|
₹28.26 | 6.08% | 31.83% | 45.15% | ₹32 | 2.35% |
Moderately High
|
|
LIC MF Equity Savings Fund
Hybrid
Regular
|
₹21.05 | 6.08% | 31.82% | 45.15% | ₹32 | 2.35% |
Moderately High
|
|
LIC MF Equity Savings Fund
Hybrid
Regular
|
₹21.05 | 6.08% | 31.82% | 45.15% | ₹32 | 2.35% |
Moderately High
|
|
LIC MF Equity Savings Fund
Hybrid
Regular
|
₹22.27 | 6.08% | 31.82% | 45.15% | ₹32 | 2.35% |
Moderately High
|
|
LIC MF Equity Savings Fund
Hybrid
Regular
|
₹22.27 | 6.08% | 31.82% | 45.15% | ₹32 | 2.35% |
Moderately High
|
|
LIC MF Large Cap Fund
Diversified
Regular
|
₹52.86 | -1.20% | 31.16% | 54.70% | ₹1,253 | 2.20% |
Very High
|
|
LIC MF Large Cap Fund
Diversified
Regular
|
₹31.92 | -1.20% | 31.16% | 54.70% | ₹1,253 | 2.20% |
Very High
|
FAQs
What is the current NAV of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
The current Net Asset Value (NAV) of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment is ₹34.04 as of 08 May 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
The Assets Under Management (AUM) of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment is ₹78.30 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment has delivered returns of 14.29% (1 Year), 24.47% (3 Year), 12.66% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
The minimum lumpsum investment required for LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹200, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
Best Mutual Funds in India: Top 5 Mid Cap Mutual Funds With More than 20% Returns in 5 Yrs -
The Best Way To Build A Mutual Fund Portfolio In Your 20s, 30s And 40s -
How To Gift Mutual Funds To Children: Rules, Tax Implications And Process Explained -
How to Position Portfolio Amid Global Tensions, Rising Gold,Silver ETF Inflows? Navi CEO Aditya Mulki Explains -
NPS vs Mutual Funds For Retirement: Which Investment Option Offers Better Growth, Tax Benefits And Stability? -
Big Shake-Up in Mutual Funds! SEBI Scraps Solution Funds, Introduces Life-Cycle Category | 5 Changes Explained -
Selling Mutual Funds? Here’s How You Can Save Capital Gains Tax Under Section 54F -
What Are Multi-Cap Mutual Funds? Single Fund Exposure to Large, Mid and Small-Cap Stocks; Know Details -
Can UAE-Based NRIs Invest In Indian Mutual Funds? Rules, Taxes And DTAA Explained -
What Is A Balanced Advantage Fund (BAF) And How Does It Work?
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+